Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

H. Ramdani; M. Falk; S. Schatz; M. Tiemann; L. Heukamp; E. Schuuring; H. Groen; F. Griesinger

doi:10.1016/j.jtho.2019.08.1568

Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

H. Ramdani, M. Falk, S. Schatz, M. Tiemann, L. Heukamp, E. Schuuring, H. Groen, F. Griesinger

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S732-S733
Number of pages	2
Journal	Journal of Thoracic Oncology
Volume	14
Issue number	10
DOIs	https://doi.org/10.1016/j.jtho.2019.08.1568
Publication status	Published - Oct-2019

Keywords

NSCLC
Immune Checkpoint Inhibitors
tumor mutational burden

Access to Document

10.1016/j.jtho.2019.08.1568

Cite this

@article{a94d3c20945d43b3a1f8879070740d6b,

title = "Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)",

keywords = "NSCLC, Immune Checkpoint Inhibitors, tumor mutational burden",

author = "H. Ramdani and M. Falk and S. Schatz and M. Tiemann and L. Heukamp and E. Schuuring and H. Groen and F. Griesinger",

year = "2019",

month = oct,

doi = "10.1016/j.jtho.2019.08.1568",

language = "English",

volume = "14",

pages = "S732--S733",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "ELSEVIER SCIENCE INC",

number = "10",

}

Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). / Ramdani, H.; Falk, M.; Schatz, S.; Tiemann, M.; Heukamp, L.; Schuuring, E.; Groen, H.; Griesinger, F.

In: Journal of Thoracic Oncology, Vol. 14, No. 10, 10.2019, p. S732-S733.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

AU - Ramdani, H.

AU - Falk, M.

AU - Schatz, S.

AU - Tiemann, M.

AU - Heukamp, L.

AU - Schuuring, E.

AU - Groen, H.

AU - Griesinger, F.

PY - 2019/10

Y1 - 2019/10

KW - NSCLC

KW - Immune Checkpoint Inhibitors

KW - tumor mutational burden

U2 - 10.1016/j.jtho.2019.08.1568

DO - 10.1016/j.jtho.2019.08.1568

M3 - Meeting Abstract

VL - 14

SP - S732-S733

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 10

ER -